RIARIFY

Medicinal product

(Invented) name

RIARIFY

Active substance (s)

Beklometazono dipropionatas/Formoterolio fumaratas dihidratas/Glikopironis

Strength

87 µg/5 µg/9 µg

Pharmaceutical form

suslėgtasis įkvepiamasis tirpalas

Route (s) of administration

įkvėpti

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

ATC code (s)

R03AL09, Formoterol, glycopyrronium bromide and beclometasone

Marketing authorisation holder

Chiesi Farmaceutici S.p.A., Italija

Date of authorisation

2018-04-23

Date of renewal

Documents

Stage

Išregistruotas

Controlled?

Controlled substance type

Legal basis

10c

Procedure number

Marketing authorisation procedure

Centrinė registracija

Qualitative and quantitative composition

Pressurised inhalation, solution	1 dozėje
Beklometazono dipropionatas	87 µg
Formoterolio fumaratas dihidratas	5 µg
Glikopironis	9 µg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To
99427	85533	1085533	inhaliatorius	60 dozių N1	Receptinis	EU/1/18/1275/001	Netiekiama	-	-	No	-	-
99428	85534	1085534	inhaliatorius	120 dozių N1	Receptinis	EU/1/18/1275/002	Netiekiama	-	-	No	-	-
99429	85536	1085536	inhaliatorius	180 dozių N1	Receptinis	EU/1/18/1275/003	Netiekiama	-	-	No	-	-
99430	85537	1085537	inhaliatorius	120 dozių N2 (240 dozių)	Receptinis	EU/1/18/1275/004	Netiekiama	-	-	No	-	-
99431	85538	1085538	inhaliatorius	120 dozių N3 (360 dozių)	Receptinis	EU/1/18/1275/005	Netiekiama	-	-	No	-	-

Stadijos

Data	Stadija
2025-03-06	Išregistruotas
2018-04-23	Registruotas